ATXS

Astria Therapeutics
ATXS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$322.80M
EV
$128.13M
Shares Outstanding
56.43M
Beta
0.38

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$28.67
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Astria Therapeutics, Inc.

gainify
ATXS

Astria Therapeutics, Inc.

ATXS

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor ...

Sector

Healthcare

Industry

Biotechnology

CEO

Milne, Jill

Employees

78

IPO Date

2015-06-25

Headquarters

75 State Street, Suite 1400, Boston, Massachusetts, 02109, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.